Soluble HLA-G and HLA-G1 Expressing Antigen-Presenting Cells Inhibit T-Cell Alloproliferation through ILT-2/ILT-4/FasL-Mediated Pathways

Human Immunology

Volumn 68, Issue 4, 2007, Pages 233-239

  Naji, Abderrahim ^a   Durrbach, Antoine ^b   Carosella, Edgardo D ^a   Rouas Freiss, Nathalie ^a  

^a Inst Univ d'Hématologie   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

Fas ligand; HLA G; ILT 2; ILT 4; T cells; transplantation

Indexed keywords

FAS ANTIGEN; FAS LIGAND; HLA G ANTIGEN; HLA G1 ANTIGEN; HLA G5 ANTIGEN; IMMUNOGLOBULIN LIKE TRANSCRIPT 2; IMMUNOGLOBULIN LIKE TRANSCRIPT 4; LYMPHOCYTE ANTIGEN RECEPTOR; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; CELL LINE, TRANSFORMED; CELL PROLIFERATION; FAS LIGAND PROTEIN; GROWTH INHIBITORS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MEMBRANE GLYCOPROTEINS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; SOLUBILITY; T-LYMPHOCYTES;

EID: 33947657929     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.10.017     Document Type: Article

References (27)

1. Walsh P.T., Strom T.B., and Turka L.A. Routes to transplant tolerance versus rejection: the role of cytokines. Immunity 20 (2004) 121
2. Lila N., Carpentier A., Amrein C., Khalil-Daher I., Dausset J., and Carosella E.D. Implication of HLA-G molecule in heart-graft acceptance. Lancet 355 (2000) 2138
3. Lila N., Amrein C., Guillemain R., Chevalier P., Latremouille C., Fabiani J.N., Dausset J., Carosella E.D., and Carpentier A. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 105 (2002) 1949
4. Creput C., Durrbach A., Menier C., Guettier C., Samuel D., Dausset J., Charpentier B., Carosella E.D., and Rouas-Freiss N. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol 39 (2003) 587
5. Creput C., Le Friec G., Bahri R., Amiot L., Charpentier B., Carosella E., Rouas-Freiss N., and Durrbach A. Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients. Hum Immunol 64 (2003) 1033
6. Carosella E.D., Moreau P., Le Maoult J., Le Discorde M., Dausset J., and Rouas-Freiss N. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 81 (2003) 199
7. Rouas-Freiss N., Marchal R.E., Kirszenbaum M., Dausset J., and Carosella E.D. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?. Proc Natl Acad Sci U S A 94 (1997) 5249
8. Riteau B., Rouas-Freiss N., Menier C., Paul P., Dausset J., and Carosella E.D. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 166 (2001) 5018
9. Riteau B., Menier C., Khalil-Daher I., Sedlik C., Dausset J., Rouas-Freiss N., and Carosella E.D. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 43 (1999) 203
10. Bahri R., Hirsch F., Josse A., Rouas-Freiss N., Bidere N., Vasquez A., Carosella E.D., Charpentier B., and Durrbach A. Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes. J Immunol 176 (2006) 1331
11. LeMaoult J., Krawice-Radanne I., Dausset J., and Carosella E.D. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci U S A 101 (2004) 7064
12. Le Rond S., Azema C., Krawice-Radanne I., Durrbach A., Guettier C., Carosella E.D., and Rouas-Freiss N. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells. J Immunol 176 (2006) 3266
13. Rajagopalan S., and Long E.O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 189 (1999) 1093
14. Colonna M., Samaridis J., Cella M., Angman L., Allen R.L., O'Callaghan C., Dunbar R., Ogg G.S., Cerundolo V., and Rolink A. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 160 (1998) 3096
15. LeMaoult J., Zafaranloo K., Le Danff C., and Carosella E.D. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J 19 (2005) 662
16. Rouas-Freiss N., LeMaoult J., Moreau P., Dausset J., and Carosella E.D. HLA-G in transplantation: a relevant molecule for inhibition of graft rejection?. Am J Transplant 3 (2003) 11
17. Le Rond S., Le Maoult J., Creput C., Menier C., Deschamps M., Le Friec G., Amiot L., Durrbach A., Dausset J., Carosella E.D., and Rouas-Freiss N. Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients. Eur J Immunol 34 (2004) 649
18. Qiu J., Terasaki P.I., Miller J., Mizutani K., Cai J., and Carosella E.D. Soluble HLA-G expression and renal graft acceptance. Am J Transplant 6 (2006) 2152
19. Luque J., Torres M.I., Aumente M.D., Marin J., Garcia-Jurado G., Gonzalez R., Pascual D., Guerra N., Lopez-Rubio F., Alvarez-Lopez M.R., Arizon J.M., and Pena J. Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy. Hum Immunol 67 (2006) 257
20. Lila N., Rouas-Freiss N., Dausset J., Carpentier A., and Carosella E.D. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A 98 (2001) 12150
21. Braud V.M., Allan D.S., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L., and McMichael A.J. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391 (1998) 795
22. Shiroishi M., Tsumoto K., Amano K., Shirakihara Y., Colonna M., Braud V.M., Allan D.S., Makadzange A., Rowland-Jones S., Willcox B., Jones E.Y., van der Merwe P.A., Kumagai I., and Maenaka K. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A 100 (2003) 8856
23. Gonen-Gross T., Achdout H., Arnon T.I., Gazit R., Stern N., Horejsi V., Goldman-Wohl D., Yagel S., and Mandelboim O. The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and {beta}2-microglobulin-free HLA-G molecules. J Immunol 175 (2005) 4866
24. Shiroishi M., Kuroki K., Ose T., Rasubala L., Shiratori I., Arase H., Tsumoto K., Kumagai I., Kohda D., and Maenaka K. Efficient leukocyte IG-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J Biol Chem 103 (2006) 16412
25. Liang S., Baibakov B., and Horuzsko A. HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur J Immunol 32 (2002) 2418
26. Fournel S., Aguerre-Girr M., Huc X., Lenfant F., Alam A., Toubert A., Bensussan A., and Le Bouteiller P. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 164 (2000) 6100
27. Desbarats J., Duke R.C., and Newell M.K. Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells. Nat Med 4 (1998) 1377